SCHEMBL4286531

SCHEMBL4286531

CCNC(=O)N(OC)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.44
OPRL1 P41146 1/20 0.44
MTNR1A P48039 4/20 0.44
MTNR1B P49286 4/20 0.44
ALDH1A1 P00352 4/20 0.44
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
GLA P06280 1/20 0.42
TSHR P16473 1/20 0.42
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.38
HPGD P15428 1/20 0.38
ALOX15 P16050 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
HSD17B10 Q99714 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7748125 0.83 MTNR1A (0.41) MTNR1AMTNR1BALDH1A1MEN1KMT2A
SCHEMBL2754165 0.83 MTNR1A (0.41) OPRM1OPRL1MTNR1AMTNR1BALDH1A1
SCHEMBL8493070 0.80 KMT2A (0.41) MTNR1AMTNR1BALDH1A1MEN1KMT2A
SCHEMBL7860796 0.80 KMT2A (0.41) MTNR1AMTNR1BALDH1A1MEN1KMT2A
SCHEMBL7860795 0.79 KMT2A (0.41) MTNR1AMTNR1BALDH1A1MEN1KMT2A
SCHEMBL1400657 0.78 NPSR1 (0.50) OPRM1OPRL1MTNR1AMTNR1BALDH1A1
SCHEMBL13543362 0.77 RAB9A (0.50) OPRM1OPRL1MTNR1AMTNR1BALDH1A1
SCHEMBL966680 0.77 OPRM1 (0.51) OPRM1OPRL1MTNR1AMTNR1BALDH1A1
SCHEMBL13499619 0.76 L3MBTL1 (0.46) MTNR1AMTNR1BALDH1A1MEN1KMT2A
SCHEMBL2325685 0.75 NPSR1 (0.44) MTNR1AMTNR1BALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8207210-B2 Aminoindazolylurea derivatives MERCK PATENT GMBH (DE) 2012-06-26 US disclosed
US-20090253767-A1 AMINOINDAZOLYLUREA DERIVATIVES MERCK PATENT GESELLSCHAFT (DE) 2009-10-08 US disclosed
US-7157457-B2 Compounds useful in the treatment of inflammatory diseases GLAXO GROUP LIMITED (GB) 2007-01-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090253767-A1 AMINOINDAZOLYLUREA DERIVATIVES SGK2, SGK1, SGK3 OPRM1 2761/4885OPRL1 2547/4885MTNR1A 3102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.